W. R. Berkley Corporation Q4 2025 Earnings Highlights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy WRB?
Source: seekingalpha
- Record Operating Earnings: W. R. Berkley Corporation reported operating earnings of $450 million or $1.13 per share in Q4 2025, reflecting a 9.5% year-over-year growth, demonstrating the company's robust profitability amidst a competitive landscape.
- Significant Underwriting Income Growth: The company achieved a record pretax underwriting income of $338 million in the fourth quarter, up 14.9% from the previous year, indicating substantial progress in its underwriting operations and strengthening its market position.
- Capital Return Strategy: In Q4, the company returned $608 million of capital to investors, including $412 million in special and regular dividends and $196 million in share repurchases, showcasing effective capital management and commitment to shareholder returns.
- Technology Investment Outlook: Management plans to increase investments in technology and AI in 2026 and 2027, which is expected to enhance operational efficiency and generate significant returns in the coming years, further solidifying the company's competitive edge.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WRB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WRB
Wall Street analysts forecast WRB stock price to rise
12 Analyst Rating
2 Buy
7 Hold
3 Sell
Hold
Current: 67.210
Low
64.00
Averages
72.25
High
84.00
Current: 67.210
Low
64.00
Averages
72.25
High
84.00
About WRB
W. R. Berkley Corporation is an insurance holding company. It operates through two segments of the property casualty insurance business: Insurance and Reinsurance & Monoline Excess. Its Insurance businesses underwrite commercial insurance business, including excess and surplus lines, admitted lines and specialty personal lines throughout the United States, as well as insurance business in Asia, Australia, Canada, Continental Europe, Mexico, Scandinavia, South America and the United Kingdom. Its Insurance segment consists of business units, including Acadia Insurance, Admiral Insurance, Berkley Accident and Health, Berkley Agribusiness and others. It provides professional liability and casualty insurance for small to mid-sized businesses though the business unit Berkley Edge. Its Reinsurance & Monoline Excess offers reinsurance business on a facultative and treaty basis in the United States, United Kingdom, Continental Europe, Australia, the Asia-Pacific region and South Africa.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
"Q1's 5 Major Insider Purchases: Should You Buy, Sell, or Hold in Q2?"
Insider Buying Trends: In Q1 2026, insiders showed strong confidence by purchasing stocks, particularly in E.W. Scripps, which had the most insider buying activity, indicating a positive outlook for the company's performance.
Institutional Support: Institutions are also actively buying stocks, owning nearly 70% of E.W. Scripps, which provides a solid support base, while analysts remain cautious with mixed ratings and sentiment.
Market Sentiment and Analyst Ratings: Despite increased coverage and a generally firm sentiment, analysts have mixed reviews, with some rating stocks as a hold, while others see potential upside, particularly in sectors like service property trusts.
Catalysts for Growth: Key catalysts for growth in various stocks include international expansion, improvements in cash flow, and advancements in technology, which could enhance performance as the year progresses.
See More
Three Promising Stocks for Investor Success
- Leidos Performance Growth: Leidos maintains a strong sales pipeline with a backlog averaging 20.2% growth over the past two years, indicating robust demand in defense, civil, and health markets, which is likely to drive future growth.
- W. R. Berkley Profitability: W. R. Berkley's net premiums earned expanded by 12.4% annually over the last five years, showcasing exceptional market penetration, while share repurchases led to a 33% annual earnings per share growth, reflecting management's investment acumen.
- Devon Energy Revenue Performance: Devon Energy achieved an impressive annual revenue growth of 27.8% over the past five years, with a revenue scale of $17.02 billion providing advantageous terms with suppliers, enabling future reinvestment or shareholder returns through free cash flow.
- Optimistic Market Outlook: All three companies demonstrate strong financial performance and competitive market positions, making them attractive for investors looking to capitalize on long-term growth potential, especially in the current economic climate where high-quality stocks can yield significant returns.
See More
W. R. Berkley Corporation Schedules Q1 2026 Earnings Release
- Earnings Release Schedule: W. R. Berkley Corporation is set to release its Q1 2026 earnings after market close on April 21, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will hold a conference call with analysts and investors on the same day at 5:00 p.m. Eastern Time to discuss earnings and other information, aiming to enhance engagement with stakeholders.
- Live Webcast Availability: The conference call will be accessible via a live audio webcast on the company's website, encouraging investors to log on early for registration, showcasing the company's use of technology to improve communication efficiency.
- Replay Arrangement: A replay of the webcast will be available on the company's website approximately two hours after the call concludes, ensuring that investors who cannot participate live can still access key information.
See More
Overview of 13D Filings
- Definition of 13D Filings: 13D filings are disclosures required to be submitted to the Securities and Exchange Commission within 10 days when an entity acquires more than 5% of any class of a company's securities, aimed at enhancing market transparency.
- Purpose of Disclosure: The primary purpose of these filings is to inform investors about changes in shareholding, which can influence market perceptions and investment decisions, thereby promoting information symmetry.
- Regulatory Requirements: Under securities law, investors holding more than 5% must promptly disclose their holdings to prevent insider trading and market manipulation, ensuring a fair trading environment.
- Market Impact: The release of 13D filings typically attracts market attention and may lead to stock price fluctuations for the affected companies, prompting investors to closely monitor these disclosures to make informed investment decisions.
See More
W R Berkley Reports In-Line Q4 Earnings with Sales Beat
- Earnings Meet Expectations: W R Berkley reported Q4 earnings of $1.13 per share, aligning perfectly with analyst consensus, indicating stable profitability for the company.
- Sales Exceed Estimates: The company achieved quarterly sales of $3.721 billion, surpassing the analyst estimate of $3.661 billion, demonstrating strong market demand.
- Slight Stock Decline: Despite the solid performance, W R Berkley shares fell 0.4% to close at $63.83 on Monday, reflecting market caution regarding future growth.
- Analyst Target Adjustments: Analysts from BofA Securities and Mizuho lowered their price targets for W R Berkley from $69 to $66 and $67 respectively, indicating a conservative outlook on the company's future performance.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
"Q1's 5 Major Insider Purchases: Should You Buy, Sell, or Hold in Q2?"
Insider Buying Trends: In Q1 2026, insiders showed strong confidence by purchasing stocks, particularly in E.W. Scripps, which had the most insider buying activity, indicating a positive outlook for the company's performance.
Institutional Support: Institutions are also actively buying stocks, owning nearly 70% of E.W. Scripps, which provides a solid support base, while analysts remain cautious with mixed ratings and sentiment.
Market Sentiment and Analyst Ratings: Despite increased coverage and a generally firm sentiment, analysts have mixed reviews, with some rating stocks as a hold, while others see potential upside, particularly in sectors like service property trusts.
Catalysts for Growth: Key catalysts for growth in various stocks include international expansion, improvements in cash flow, and advancements in technology, which could enhance performance as the year progresses.
See More
Three Promising Stocks for Investor Success
- Leidos Performance Growth: Leidos maintains a strong sales pipeline with a backlog averaging 20.2% growth over the past two years, indicating robust demand in defense, civil, and health markets, which is likely to drive future growth.
- W. R. Berkley Profitability: W. R. Berkley's net premiums earned expanded by 12.4% annually over the last five years, showcasing exceptional market penetration, while share repurchases led to a 33% annual earnings per share growth, reflecting management's investment acumen.
- Devon Energy Revenue Performance: Devon Energy achieved an impressive annual revenue growth of 27.8% over the past five years, with a revenue scale of $17.02 billion providing advantageous terms with suppliers, enabling future reinvestment or shareholder returns through free cash flow.
- Optimistic Market Outlook: All three companies demonstrate strong financial performance and competitive market positions, making them attractive for investors looking to capitalize on long-term growth potential, especially in the current economic climate where high-quality stocks can yield significant returns.
See More
W. R. Berkley Corporation Schedules Q1 2026 Earnings Release
- Earnings Release Schedule: W. R. Berkley Corporation is set to release its Q1 2026 earnings after market close on April 21, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will hold a conference call with analysts and investors on the same day at 5:00 p.m. Eastern Time to discuss earnings and other information, aiming to enhance engagement with stakeholders.
- Live Webcast Availability: The conference call will be accessible via a live audio webcast on the company's website, encouraging investors to log on early for registration, showcasing the company's use of technology to improve communication efficiency.
- Replay Arrangement: A replay of the webcast will be available on the company's website approximately two hours after the call concludes, ensuring that investors who cannot participate live can still access key information.
See More
Overview of 13D Filings
- Definition of 13D Filings: 13D filings are disclosures required to be submitted to the Securities and Exchange Commission within 10 days when an entity acquires more than 5% of any class of a company's securities, aimed at enhancing market transparency.
- Purpose of Disclosure: The primary purpose of these filings is to inform investors about changes in shareholding, which can influence market perceptions and investment decisions, thereby promoting information symmetry.
- Regulatory Requirements: Under securities law, investors holding more than 5% must promptly disclose their holdings to prevent insider trading and market manipulation, ensuring a fair trading environment.
- Market Impact: The release of 13D filings typically attracts market attention and may lead to stock price fluctuations for the affected companies, prompting investors to closely monitor these disclosures to make informed investment decisions.
See More
W R Berkley Reports In-Line Q4 Earnings with Sales Beat
- Earnings Meet Expectations: W R Berkley reported Q4 earnings of $1.13 per share, aligning perfectly with analyst consensus, indicating stable profitability for the company.
- Sales Exceed Estimates: The company achieved quarterly sales of $3.721 billion, surpassing the analyst estimate of $3.661 billion, demonstrating strong market demand.
- Slight Stock Decline: Despite the solid performance, W R Berkley shares fell 0.4% to close at $63.83 on Monday, reflecting market caution regarding future growth.
- Analyst Target Adjustments: Analysts from BofA Securities and Mizuho lowered their price targets for W R Berkley from $69 to $66 and $67 respectively, indicating a conservative outlook on the company's future performance.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
